drugset / Trial / NCT00864747
A Relative Bioavailability Study of Propranolol HCl 160 mg Tablets Under Non-fasting Conditions
RandomizedCrossoverOpen-label
Summary
The purpose of this study is to compare the relative bioavailability of Propranolol Hydrochloride Extended Release Capsules 160 mg (Actavis) with that of INDERAL® LA 160 mg Capsules (Wyeth Pharmaceuticals) following a single oral dose (1 x 160 mg) in healthy adult volunteers under non-fasting conditions.
Timeline
- Start
- 2005-05
- Primary completion
- 2005-05
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Propranolol | Small molecule | 160 mg | Oral |
Indications
No indication recorded.